Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial
about
Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial
description
scientific article published on 14 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Efficacy and Safety of an Afli ...... Single-Arm, Multicentre Trial
@en
Efficacy and Safety of an Afli ...... Single-Arm, Multicentre Trial
@nl
type
label
Efficacy and Safety of an Afli ...... Single-Arm, Multicentre Trial
@en
Efficacy and Safety of an Afli ...... Single-Arm, Multicentre Trial
@nl
prefLabel
Efficacy and Safety of an Afli ...... Single-Arm, Multicentre Trial
@en
Efficacy and Safety of an Afli ...... Single-Arm, Multicentre Trial
@nl
P2093
P2860
P50
P356
P1476
Efficacy and Safety of an Afli ...... Single-Arm, Multicentre Trial
@en
P2093
Alex Fonollosa
Enrique Cervera
Francisco Gómez-Ulla
Jaume Crespí
Javier Araiz
Lucia Manzanas
Marta Suárez de Figueroa
Roberto Gallego
P2860
P304
P356
10.1155/2018/8310350
P407
P577
2018-10-14T00:00:00Z